EMTN Programme Routine Technical Update: Publication of Prospectus
11 June 2020 07:00 BST EMTN Programme Routine Technical Update: Publication of Prospectus Following a routine technical update of the Company's Euro Medium Term Note ("EMTN") programme established in 2007, the following prospectus has been approved by the Financial Conduct Authority and is available for viewing: Base Prospectus for the AstraZeneca PLC U.S. $10,000,000,000 Euro Medium Term Note Programme (the "Prospectus"). The last drawdown under the EMTN programme was in 2016. To view the full document, please paste the following URL into the address bar of your browser.